SANKYO C25 Pill - pink oval, 15mm
Generic Name: hydrochlorothiazide/olmesartan
Pill with imprint SANKYO C25 is Pink, Oval and has been identified as Benicar HCT 25 mg / 40 mg. It is supplied by Sankyo Pharma.
Benicar HCT is used in the treatment of High Blood Pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Benicar HCT 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SANKYO C25
Benicar HCT
- Generic Name
- hydrochlorothiazide/olmesartan
- Imprint
- SANKYO C25
- Strength
- 25 mg / 40 mg
- Color
- Pink
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Angiotensin II inhibitors with thiazides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sankyo Pharma
- Inactive Ingredients
-
hydroxypropyl cellulose,
hypromelloses,
lactose monohydrate,
low substituted hydroxypropyl cellulose,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65597-0107 (Discontinued) | Daiichi Sankyo Inc. |
| 57664-0760 | Caraco Pharmaceutical Laboratories, Ltd. |
| 54868-5078 (Discontinued) | Physicians Total Care Inc. (repackager) |
| 54569-5903 | A-S Medication Solutions, LLC (repackager) |
| 55289-0443 (Discontinued) | PDRX Pharmaceuticals Inc. (repackager) |
| 35356-0258 | Lake Erie Medical and Surgical Supply (repackager) |
| 35356-0289 | Lake Erie Medical and Surgical Supply (repackager) |
Related images for "SANKYO C25"
More about Benicar HCT (hydrochlorothiazide / olmesartan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: angiotensin II inhibitors with thiazides
- En español
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
